USPTO 2015–2025 USPTO PatentsView US Corporation

PBI Performance Products, Inc.

USPTO PatentsView assignee record - 18 granted patents across 20 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds).

RSS updates for this company

The verdict

According to USPTO PatentsView, PBI ranks #16,276 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 20 technology areas.

#16,276
of 49,997 US assignees by volume
Top 40%
by Innovation Score (38.9/100)
10.3
avg claims per patent
-62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16276 · US Corporation #16,276 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 18 grants
  • MID-PACK #16,276/49,997
  • PHOTO-FINISH Oyster Point Pharma
  • CPC-FOCUS C08G · 20 areas
  • INNOV-THIN 38.9/100
  • CLAIMS-PAR 10.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -62% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oyster Point Pharma, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How PBI’s 38.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around PBI

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows PBI's Innovation Score is 38.9/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for PBI?

Each dot is one of PBI’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). PBI’s own 10.3 claims/patent is at or below the 12.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

PBI vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 17.917.91818.1 510152025 Granted patents (volume) Avg claims / patent Oyster Point Pharma, Inc. - 18, 23.39Oyster Point Phar…PAI Lung Machinery Mill Co., Ltd. - 18, 7.56PAI Lung Machiner…PAR Systems, LLC - 18, 20.33PAR SystemsParcus Medical, LLC - 18, 14.5Parcus MedicalPexip AS - 18, 14.44Pexip ASPFC Device Holdings Limited - 18, 8.56PFC Device Holdin…Playtech Software Limited - 18, 11.33Playtech SoftwarePMD Technologies AG - 18, 12PMDPBI Performance Products, Inc. - 18, 10.33PBI Performance P…
PBI vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where PBI's grants concentrate

PBI Performance Products, Inc. is a focused PatentsView assignee: 20 CPC subclasses with 55.6% of grants classified under C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2018. By volume, PBI sits between Oyster Point Pharma, Inc. and PMD Technologies AG.

PBI's three-year grant acceleration

PBI Performance Products, Inc. shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at PBI's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows PBI holds 18 patents at rank #16,272, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near PBI

By rank, the assignees closest to #16,272 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise Than BY React…)

Other assignees with the most granted patents in PBI's primary technology class.

PBI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20152016201720182019202020212024 3
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
PBI Performance Products, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 16.7%
2016 4 22.2%
2017 4 22.2%
2018 1 5.6%
2019 1 5.6%
2020 1 5.6%
2021 1 5.6%
2024 3 16.7%

Which technologies does PBI Performance Products, Inc. patent most?

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

PBI Performance Products, Inc.'s patent record in context - here's where to go next.

  • PBI Performance Products, Inc.'s lead technology class is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds), 55.6% of its portfolio - see every assignee active in that class. Explore C08G
  • Ranked #16,276 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare PBI Performance Products, Inc. against Oyster Point Pharma, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.